NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-238-2015-0-EP-06 MOLECULAR NANOTAGS EP National Stage 17809073.4 Issued
NCI E-238-2015-0-FR-11 MOLECULAR NANOTAGS FR EP 17809073.4 Issued
NCI E-238-2015-0-DE-10 MOLECULAR NANOTAGS DE EP 17809073.4 Issued
NCI E-238-2015-0-PCT-02 MOLECULAR NANOTAGS PCT PCT PCT/US2017/057928 Expired
NCI E-238-2015-0-JP-07 MOLECULAR NANOTAGS JP National Stage 2019-521089 Pending
NIA E-249-2016-0-RU-12 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE RU National Stage 2019115110 Issued
NCI E-149-2015-0-AU-03 Methods of Isolating T Cells and T Cell Receptors Having Antigen Specificaity for a Cancer-Specific Mutation from Peripheral Blood AU National Stage 2016258845 Issued
NIA E-249-2016-0-US-14 Exendin-4, GLP-1, GIP And Related Analogs – Optimal Use For Mitigating Neurological Disorders US National Stage 16/342,685 11273130 Issued PDF
NIA E-249-2016-0-ZA-16 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE ZA National Stage 2019/02486 Issued
NIA E-249-2016-0-KR-10 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE KR National Stage 10-2019-7014421 Pending
NIA E-249-2016-0-SG-13 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE SG National Stage 11201903462U Abandoned
NIA E-249-2016-0-VN-15 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE VN National Stage 1-2019-02535 Pending
NIA E-249-2016-0-MX-11 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE MX National Stage MX/a/2019/004476 Pending
NIA E-249-2016-0-JP-09 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE JP National Stage 2019-521018 Pending
NIA E-249-2016-0-AU-03 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE AU National Stage 2017345724 Pending
NIA E-249-2016-0-BR-04 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE BR National Stage 1120190080210 Pending
NIA E-249-2016-0-EP-07 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM EP National Stage 17800650.8 Pending
NIA E-249-2016-0-IN-08 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE IN National Stage 201917018680 Pending
NIA E-249-2016-0-PCT-02 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE PCT PCT PCT/US2017/057606 Expired
NIA E-249-2016-0-CN-06 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM CN National Stage 201780078697.6 Pending
NIA E-249-2016-0-CA-05 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE CA National Stage 3040906 Pending
NCI E-015-2011-0-AU-07 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer AU DIV 2017248517 Issued
NCI E-174-2018-2-EP-09 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer EP National Stage 17861792.4 Issued
NCI E-174-2018-2-JP-08 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer JP National Stage 2019-520738 Issued
NCI E-174-2018-2-AU-04 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer AU National Stage 2017346885 Issued
NCI E-174-2018-2-GB-03 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer GB National Stage 1906855.0 Issued
NCI E-289-2011-0-AU-20 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF AU DIV 2017248462 Issued
NCI E-495-2013-0-US-09 ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS US CON 15/786,966 10329339 Issued PDF
NCI E-174-2018-2-PCT-01 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer PCT PCT COMB PCT/US2017/057228 Expired
NCI E-174-2018-2-CN-06 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer CN National Stage 201780078471.6 Pending
NCI E-174-2018-2-CA-05 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer CA National Stage 3041068 Pending
NCI E-149-2015-0-US-05 METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD US National Stage 15/567,157 10544392 Issued PDF
NIAID E-101-2018-0-PCT-02 Multi-Specific Antibodies Targeting Human Immunodeficiency Virus And Methods Of Using The Same PCT PCT PCT/US2017/057053 Expired
NIDCR E-160-2000-1-US-10 T2R, A NOVEL FAMILY OF TASTE RECEPTORS US DIV 15/786,468 Abandoned
NIAID E-101-2018-0-EP-03 Multi-Specific Antibodies Targeting Human Immunodeficiency Virus And Methods Of Using The Same EP National Stage 17862065.4 Pending
NCI E-033-2013-1-US-05 STABILIZED SINGLE HUMAN CD4 DOMAINS AND FUSION PROTEINS US CON 15/784,988 10647754 Issued PDF
NCATS E-091-2016-0-IN-06 METHOD OF BLOCKING TRANSMISSION OF MALARIAL PARASITE IN National Stage 201917014688 Issued
NIMH E-448-2013-0-US-05 Antineuronal Antibodies In Pediatric Acute Neurologic Syndrome For Diagnosis And Treatment US CON 15/783,541 10228376 Issued PDF
NCATS E-091-2016-0-PCT-02 METHOD OF BLOCKING TRANSMISSION OF MALARIAL PARASITE PCT PCT PCT/US2017/056619 Expired
NCATS E-091-2016-0-BR-03 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF
MALARIAL PARASITE 		BR National Stage BR1120190075941 Pending
NHGRI E-007-1999-2-JP-12 Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers JP DIV 2017-199639 Expired
NCATS E-091-2016-0-EP-05 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE EP National Stage 17797478.9 Pending
NCI E-276-2016-0-AU-03 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS AU National Stage 2017343643 Issued
NEI E-050-2015-0-FR-11 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa FR EP 16762623.3 Issued
NEI E-050-2015-0-DE-10 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa DE EP 16762623.3 Issued
NEI E-050-2015-0-GB-12 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa GB EP 16762623.3 Issued
NEI E-050-2015-0-EP-06 RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa EP National Stage 16762623.3 Issued
NIAID E-257-2016-0-PCT-02 TREATMENT OF TUMORS BY INHIBITION OF CD300F PCT PCT PCT/US2017/056192 Expired
NCI E-276-2016-0-PCT-02 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS PCT PCT PCT/US2017/056124 Expired
NCI E-276-2016-0-CA-04 HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS CA National Stage 3039997 Pending